Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Current Opinion in Lipidology|March 14, 2013
Peroxisome proliferator-activated receptor δ: a multifaceted metabolic playerLazar A Bojic, Murray W HuffCurrent Opinion in Investigational Drugs (London, England : 2000)|December 25, 2002
Avasimibe PfizerJohn R Burnett, Murray W HuffExpert Opinion on Investigational Drugs|October 17, 2006
Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemiaJohn R Burnett, Murray W HuffTrends in Pharmacological Sciences|June 14, 2005
Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clearMurray W Huff, Dawn E TelfordThe Canadian Journal of Cardiology|April 14, 2010
Antiatherogenic properties of flavonoids: implications for cardiovascular healthErin E Mulvihill, Murray W HuffCardiovascular & Hematological Disorders Drug Targets|October 4, 2012
Citrus flavonoids and the prevention of atherosclerosisErin E Mulvihill, Murray W HuffArteriosclerosis, Thrombosis, and Vascular Biology|February 4, 2017
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in <i>Ldlr</i> Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic AcidJoshua P Samsoondar, Amy C Burke, Brian G Sutherland, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2018
Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (<i>LDLR</i><sup>+/-</sup> and <i>LDLR</i><sup>-/-</sup>) Yucatan Miniature PigsAmy C Burke, Dawn E Telford, Brian G Sutherland, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 16, 2006
NPC1L1: evolution from pharmacological target to physiological sterol transporterMurray W Huff, Rebecca L Pollex, Robert A HegeleCurrent Opinion in Lipidology|December 21, 2012
Citrus flavonoids and lipid metabolismJulia M Assini, Erin E Mulvihill, Murray W HuffPageof 7